These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8356400)

  • 1. Specific activation of human peripheral blood gamma/delta + lymphocytes by sonicated antigens of Mycobacterium tuberculosis: role in vitro in killing human bladder carcinoma cell lines.
    Wang MH; Chen YQ; Gercken J; Ernst M; Böhle A; Flad HD; Ulmer AJ
    Scand J Immunol; 1993 Sep; 38(3):239-46. PubMed ID: 8356400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of bacillus-Calmette-Guérin-activated killer cells from human peripheral blood mononuclear cells against human bladder carcinoma cell lines in vitro.
    Thanhäuser A; Böhle A; Flad HD; Ernst M; Mattern T; Ulmer AJ
    Cancer Immunol Immunother; 1993 Jul; 37(2):105-11. PubMed ID: 8319241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
    Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
    J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro generation of bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Böhle A; Thanhäuser A; Ernst M; Mattern T; Ulmer AJ; Flad HD
    Clin Infect Dis; 2000 Sep; 31 Suppl 3():S94-S100. PubMed ID: 11010832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant bacillus Calmette-Guérin (BCG) expressing interferon-alpha 2B enhances human mononuclear cell cytotoxicity against bladder cancer cell lines in vitro.
    Liu W; O'Donnell MA; Chen X; Han R; Luo Y
    Cancer Immunol Immunother; 2009 Oct; 58(10):1647-55. PubMed ID: 19214503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
    Hoft DF; Brown RM; Roodman ST
    J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells.
    Luo Y; Yamada H; Evanoff DP; Chen X
    Clin Exp Immunol; 2006 Oct; 146(1):181-8. PubMed ID: 16968412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the immunobiological effects of Bacillus Calmette-Guérin (BCG) in vitro: evidence of a distinct BCG-activated killer (BAK) cell phenomenon.
    Böhle A; Thanhäuser A; Ulmer AJ; Ernst M; Flad HD; Jocham D
    J Urol; 1993 Dec; 150(6):1932-7. PubMed ID: 8230540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-major histocompatibility complex-restricted cytotoxic activity of blood mononuclear cells stimulated with secreted mycobacterial proteins and other mycobacterial antigens.
    Ravn P; Pedersen BK
    Infect Immun; 1994 Dec; 62(12):5305-11. PubMed ID: 7960109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
    Wang F; Zhang G; Xu T; Ma J; Wang J; Liu S; Tang Y; Jin S; Li J; Xing N
    J Exp Clin Cancer Res; 2024 Jan; 43(1):24. PubMed ID: 38245792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines.
    Wang MH; Flad HD; Böhle A; Chen YQ; Ulmer AJ
    Immunol Lett; 1991 Mar; 27(3):191-7. PubMed ID: 2060970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guerin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumour cell killing.
    Pryor K; Goddard J; Goldstein D; Stricker P; Russell P; Golovsky D; Penny R
    Br J Cancer; 1995 Apr; 71(4):801-7. PubMed ID: 7710947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the mononuclear phagocyte as an antigen-presenting cell for human gamma delta T cells activated by live Mycobacterium tuberculosis.
    Boom WH; Chervenak KA; Mincek MA; Ellner JJ
    Infect Immun; 1992 Sep; 60(9):3480-8. PubMed ID: 1379984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific activation of resting T cells against tumour cells by bispecific antibodies and CD28-mediated costimulation is accompanied by Th1 differentiation and recruitment of MHC-independent cytotoxicity.
    Hombach A; Tillmann T; Jensen M; Heuser C; Sircar R; Diehl V; Kruis W; Pohl C
    Clin Exp Immunol; 1997 May; 108(2):352-7. PubMed ID: 9158110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
    Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of bacillus-Calmette-Guérin-activated killer cells requires the presence of monocytes and T-helper type-1 cells.
    Thanhäuser A; Böhle A; Schneider B; Reiling N; Mattern T; Ernst M; Flad HD; Ulmer AJ
    Cancer Immunol Immunother; 1995 Feb; 40(2):103-8. PubMed ID: 7882379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin.
    Esin S; Batoni G; Pardini M; Favilli F; Bottai D; Maisetta G; Florio W; Vanacore R; Wigzell H; Campa M
    Immunology; 2004 May; 112(1):143-52. PubMed ID: 15096193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis.
    Al-Attiyah R; Mustafa AS; Abal AT; El-Shamy AS; Dalemans W; Skeiky YA
    Clin Exp Immunol; 2004 Oct; 138(1):139-44. PubMed ID: 15373916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer.
    Sänger C; Busche A; Bentien G; Spallek R; Jonas F; Böhle A; Singh M; Brandau S
    BMC Cancer; 2004 Nov; 4():86. PubMed ID: 15566565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.